RNA-seq can also classify the subtypes of B-ALL and fusions detections16, whereas our sequential approach can identify patients with kinase fusions or CRLF2 rearrangements although we could not determine whether patients with CRLF2 rearrangements were Ph-like ALL. This evidence concerns the gene CRLF2 and acute lymphoblastic leukemia.